Reactogenicity, Safety and Immunogenicity of an Universal Influenza Vaccine Uniflu

NCT03789539 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety Issues

Interventions

BIOLOGICAL: LD Universal Influenza Vaccine Uniflu
BIOLOGICAL: HD Universal Influenza Vaccine Uniflu
BIOLOGICAL: Placebo

Sponsor

VA Pharma Limited Liability Company